[Asia Economy Reporter Hwang Yoon-joo]
▲Magic Micro = Adverse audit opinion, inquiry disclosure requested
▲ST Pharm = Approval for Phase 1 clinical trial of mRNA vaccine targeting Omicron variant
▲Inbio = Re-disclosure of embezzlement charges against former executives... "Complaint filed after specifying estimated damages"
▲Vespa = Fully capital impaired... Recent cause for delisting occurred
▲Oscotec = Decision on a 30 billion KRW paid-in capital increase
▲KPX Life Science = Changed to dual CEO system with Yang Jun-hwa and Lee Ki-sung
▲DKT = Loan of 6.1 billion KRW to affiliate BHEVS
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- CLC: "Second Post-Adjustment Negotiation Between Samsung Electronics Management and Labor Ends"...To Resume Tomorrow Morning (Comprehensive)
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
▲Sejong Medical = Decision to transfer land and buildings worth 9 billion KRW
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
